Our Patient Assistance Program (PAP) helps eligible members access prescription savings programs for high-cost medications, improving adherence and reducing overall pharmacy spend by up to 60%. Unlike vendors that focus only on specialty drugs, we take a broader approach—identifying non-specialty medications that may qualify for alternative funding sources. While individual non-specialty savings may be smaller, the higher utilization creates meaningful aggregate cost reductions.
By combining strategic identification, member support, and expanded eligibility review, our PAP Program helps self-funded plans manage rising drug costs with precision and measurable impact.
Ensures high-cost medications are accessible to members while controlling overall pharmacy spend, driving measurable plan efficiency.
Identifies non-specialty medications eligible for alternative funding sources, unlocking cost savings across a wider population of prescriptions.
Combines strategic identification, eligibility review, and member-focused guidance to improve medication adherence. Members receive the support they need, while plans gain greater control over rising drug costs.